FDA Import Refusal SCS-1304138-1/11/1 — VICENTE ANTONIO ESCOBAR RESTREPO--
The FDA refused shipment SCS-1304138-1/11/1 from VICENTE ANTONIO ESCOBAR RESTREPO-- (Colombia) on Sep 5, 2020. The refused product falls under Drugs and Biologics — CLONAZEPAM (ANTI-CONVULSANT). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Sep 5, 2020
- Country
- Colombia
- Product Category
- Drugs and Biologics
- Product Code
- 61MCY06 CLONAZEPAM (ANTI-CONVULSANT)
- Charges
- 75